Dr. Bishop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
19 Sturdy St
Attleboro, MA 02703Phone+1 508-236-8525
Summary
- Dr. Kenneth Bishop is an oncologist in Attleboro, MA and is affiliated with Providence Veterans Affairs Medical Center. He received his medical degree from University of Massachusetts Medical School and has been in practice 9 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
- Brown UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
- Brown UniversityResidency, Internal Medicine, 2008 - 2012
- University of Massachusetts Medical SchoolClass of 2008
- Gordon CollegeBS, Biology, Magna Cum Laude, 1994 - 1998
Certifications & Licensure
- MA State Medical License 2017 - 2026
- RI State Medical License 2008 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Alpha Omega Alpha Alpha Omega Alpha, 2011
- College Dean’s List Gordon College, 1995
- Presidential Scholarship Gordon College, 1994
Publications & Presentations
PubMed
- 98 citationsEarly Growth Response Gene-2, a Zinc-Finger Transcription Factor, Is Required for Full Induction of Clonal Anergy in CD4+ T CellsJohn E. Harris, Kenneth D. Bishop, Nancy E. Phillips, John P. Mordes, Dale L. Greiner
Journal of Immunology. 2004-12-15 - 36 citationsCompliance and falsification of duty hours: reports from residents and program directors.Brian C. Drolet, Matthew Schwede, Kenneth D. Bishop, Staci A. Fischer
Journal of Graduate Medical Education. 2013-09-06 - 15 citationsFOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study.Howard Safran, Kevin P. Charpentier, Kimberly Perez, Kalyan Mantripragada, Thomas J. Miner
American Journal of Clinical Oncology. 2016-12-01
Journal Articles
- Epidemiology and survival outcomes of ocular and mucosal melanomas: A population-based analysisBishop KD, Olszewski AJ, Int J Cancer, 6/1/2014
- Viral lymphomagenesis: from pathophysiology to the rationale for novel therapiesCastillo JJ, Reagan JL, Bishop KD, Apor E, Br J Haematol, 5/1/2014
- Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignanciesCastillo JJ, Iyengar M, Kuritzky B, Bishop KD, Onco Targets Ther., 2/21/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Survival and Outcomes in Mucosal Melanoma. (Poster)Bishop KD, and Olszewski A, ASCO Annual Meeting, Chicago, IL, 6/1/2013
- House Staff Perception of Duty Hour and Supervision Regulation: Results from a National Survey. (Poster)Bishop KD. Drolet BC, Tammaro D, Fischer SA, APDIM Program Directors Meeting, Phoenix, AZ, 10/11/2012
- Concurrent Ehrlichia and Parvovirus infection in a 31-year-old woman. (Poster)Bishop KD and Gentilesco BA, American College of Physicians Annual Rhode Island Meeting, Warwick, RI, 5/1/2012
- Join now to see all
Lectures
- Targeted therapy in Lung Cancer.Comprehensive Cancer Center of Rhode Island Hospital, Providence, RI - 5/1/2014
- Emergency room utilization by patients with lung cancer.Alexandria, VA - 3/6/2014
- Tumor Immunity.Comprehensive Cancer Center of Rhode Island Hospital, Providence, RI - 6/29/2013
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: